Byosen provides an advanced continuous monitoring system that uses biosensor technology to track neurophysiological signals for mental healthcare. The platform delivers real‑time biosensing intelligence to insurers, enabling more predictable behavioral health risk assessment and integration into care management programs, helping reduce costs and improve patient outcomes.
Funding
Funding not disclosed
Founders
Product
Problem
Insurers, providers, and government health programs lack objective, real‑time data on patients’ mental health status, making it difficult to predict behavioral health risk, manage care efficiently, and control costs.
Solution
Byosen offers a continuous monitoring platform that captures neurophysiological signals through wearable biosensors. The system streams real‑time biosensing intelligence to payers, enabling integration of objective risk metrics into care‑management workflows and treatment monitoring. By providing quantifiable biomarkers of mental health, the platform supports more precise risk stratification, early intervention, and outcome tracking. Insurers can use the data to adjust care plans, allocate resources, and evaluate treatment effectiveness, ultimately aiming to reduce overall expenditures while improving patient outcomes.
Target Audience
Primary customers are health insurers, managed‑care organizations, and government health agencies that oversee behavioral health programs and seek data‑driven risk management tools.
Features
- Wearable biosensor hardware that continuously records neurophysiological signals relevant to mental health
- Cloud‑based analytics engine that transforms raw sensor data into actionable risk scores and trend visualizations
- API integration for seamless embedding of biosensing intelligence into existing payer and provider care‑management platforms
- Real‑time alerts and dashboards that highlight deviations from baseline, supporting proactive intervention
- Compliance‑focused data handling with encryption and HIPAA‑aligned security controls